Ligand ID: FVX Drugbank ID: DB00176(Fluvoxamine) Indication:Indicated predominantly for the management of depression and for Obsessive Compulsive Disorder (OCD) [FDA Label]. Has also been used in the management of bulimia nervosa [A250]. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 1q2w | 3C-LIKE PROTEASE (SARSr-CoV) | 5 / 9 | ASP A 153SER A 158SER B 123GLY B 124THR A 292 | 1.68A | 20.55 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 1uk3 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 220ILE B 259ALA B 260THR B 224ALA B 267 | 1.26A | 21.46 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 1wnc | E2 GLYCOPROTEIN (SARSr-CoV) | 6 / 12 | LEU A 927ILE A1160ALA B 926THR B 923ALA C 926THR C 923 | 1.69A | 13.79 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 1xak | ORF7A ACCESSORYPROTEIN (SARSr-CoV) | 5 / 11 | ALA A 49TYR A 60PHE A 31SER A 29GLY A 27 | 1.63A | 10.00 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 1zv8 | E2 GLYCOPROTEIN (SARSr-CoV) | 6 / 12 | LEU C 27ILE B 12ALA E 26THR E 23ALA A 26THR A 23 | 1.63A | 7.46 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2acf | REPLICASEPOLYPROTEIN 1AB (SARS-COVTor2) | 5 / 12 | LEU C 235ILE C 217ALA C 271ALA C 238THR C 239 | 1.23A | 19.23 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2amq | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 220ILE A 259ALA A 260THR A 224ALA A 267 | 1.29A | 21.62 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2amq | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.61A | 20.73 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2beq | SPIKE GLYCOPROTEIN (SARSr-CoV) | 6 / 12 | LEU B 927ILE D1161ALA C 926THR C 923ALA A 926THR A 923 | 1.63A | 5.92 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2dd8 | IGG HEAVY CHAINIGG LIGHT CHAIN (Homosapiens) | 5 / 9 | SER L 178SER H 179SER H 180GLY H 139THR L 115 | 1.55A | 15.70 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 2dd8 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 11 | ALA S 406TYR S 410PHE S 416GLY S 400ASP S 385 | 1.22A | 18.51 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2fav | REPLICASEPOLYPROTEIN 1AB(PP1AB) (ORF1AB) (SARSr-CoV) | 5 / 12 | LEU A 54ILE A 36ALA A 90ALA A 57THR A 58 | 1.23A | 19.58 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 2fe8 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 11 | ALA C 140TYR C 137GLY C 101SER C 104GLY C 143 | 1.58A | 22.39 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 2ghv | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 11 | ALA E 406TYR E 410PHE E 416GLY E 400ASP E 385 | 1.27A | 15.38 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2ghw | ANTI-SCFV ANTIBODY,80RSPIKE GLYCOPROTEIN (Homosapiens;SARSr-CoV) | 5 / 9 | ASN C 479SER D 163PHE D 203SER D 184SER D 195 | 1.71A | 16.94 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 2gri | NSP3 (SARSr) | 5 / 11 | VAL A 62ALA A 61PHE A 88SER A 84ASP A 29 | 1.33A | 14.39 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2h85 | PUTATIVE ORF1ABPOLYPROTEIN (SARSr-CoV) | 6 / 12 | PHE A 329LEU A 297ILE A 295ILE A 305THR A 192ALA A 325 | 1.71A | 21.17 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2k87 | NSP3 OF REPLICASEPOLYPROTEIN 1A (SARSr) | 5 / 9 | ASP A 21SER A 47PHE A 42GLY A 41THR A 26 | 1.48A | 11.48 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2ozk | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 6 / 12 | PHE C 329LEU C 297ILE C 295ILE C 305THR C 321ALA C 325 | 1.43A | 21.73 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2pwx | 3C-LIKE PROTEINASE (SARS-COVBJ01) | 5 / 12 | ALA A 193THR A 196GLY A 138ALA A 173THR A 135 | 1.25A | 21.68 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2q6g | REPLICASEPOLYPROTEIN 1AB (SARS-COVBJ01) | 5 / 12 | LEU A 220ILE A 259ALA A 260THR A 224ALA A 267 | 1.30A | 21.46 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2qc2 | 3C-LIKE PROTEINASE (-) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.62A | 20.84 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 6 / 12 | PHE B 302LEU B 331ILE B 306ALA B 234GLY B 246THR B 340 | 1.56A | 21.71 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2rhb | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARSr-CoV) | 5 / 9 | ASP F 267ILE D 42SER F 273GLY D 13THR D 33 | 1.69A | 21.42 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 2vj1 | MAIN PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.73A | 20.33 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 3aw0 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 282ILE A 281ALA A 206GLY A 258ALA A 211 | 1.27A | 21.46 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 3bgf | SPIKE PROTEIN S1 (SARSr-CoV) | 5 / 11 | ALA S 406TYR S 410PHE S 416GLY S 400ASP S 385 | 1.22A | 14.88 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3bgf | F26G19 FAB (Musmusculus) | 5 / 9 | ASN C 161SER B 180SER B 181GLY B 141THR C 114 | 1.19A | 15.50 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3e91 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.60A | 20.70 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 3e9s | NSP3 (SARSr-CoV) | 5 / 11 | ALA A 140TYR A 137GLY A 101SER A 104GLY A 143 | 1.51A | 22.35 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 3ea7 | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 220ILE A 259ALA A 260THR A 224ALA A 267 | 1.30A | 21.68 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 3f9e | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | ALA A 193THR A 196GLY A 138ALA A 173THR A 135 | 1.27A | 21.88 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 3f9e | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 11 | VAL A 157GLY A 11SER A 113GLY A 149ASP A 155 | 1.44A | 20.67 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3f9g | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.73A | 20.36 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 3f9h | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 11 | ASP A 216ALA B 140GLY A 283PHE A 3GLY A 2 | 1.62A | 20.87 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 3i6l | HLA, A-24 (Homosapiens) | 5 / 11 | ASP D 102VAL D 28GLY D 100GLY D 167ASP D 30 | 1.59A | 20.15 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3m3s | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.70A | 20.70 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU B 220ILE B 259ALA B 260THR B 224ALA B 267 | 1.18A | 21.68 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3m3v | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 292 | 1.55A | 20.84 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 3r24 | 2'-O-METHYLTRANSFERASENSP10 AND NSP11 (SARSr-CoV) | 5 / 12 | ALA A 107THR A 82ALA A 79GLY A 77ALA B 71 | 1.30A | 18.22 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 3snd | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP A 153SER A 158SER B 123GLY B 124THR A 292 | 1.64A | 20.70 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 4m0w | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 11 | ALA A 140TYR A 137GLY A 101SER A 104GLY A 143 | 1.56A | 22.30 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 4mm3 | PAPAIN-LIKEPROTEINASE (SARSr-CoV) | 5 / 11 | ALA B 140TYR B 137GLY B 101SER B 104GLY B 143 | 1.51A | 22.35 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 4rna | PAPAIN-LIKE PROTEASE (Humanbetacoronavirus2cEMC/2012) | 6 / 12 | PHE A 79LEU A 133ILE A 130ALA A 150GLY A 12ALA A 132 | 1.80A | 22.42 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5b6o | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 12 | LEU A 220ILE A 259ALA A 260THR A 224ALA A 267 | 1.28A | 21.00 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 5c5o | 3C-LIKE PROTEINASE (SARSr-CoV) | 5 / 9 | ASP B 153SER B 158SER A 123GLY A 124THR B 111 | 1.64A | 20.88 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5e6j | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 11 | ALA D 140TYR D 137GLY D 101SER D 104GLY D 143 | 1.60A | 22.30 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5tl6 | REPLICASEPOLYPROTEIN 1AB (SARSr-CoV) | 5 / 11 | ALA B 140TYR B 137GLY B 101SER B 104GLY B 143 | 1.42A | 22.22 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5wrg | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | PHE B 741ILE B 724ILE B 975GLY A 981THR B 980 | 1.25A | 16.36 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5x4r | S PROTEIN (MERS-CoV) | 5 / 12 | ILE A 143ILE A 300ALA A 89ALA A 138GLY A 128 | 1.30A | 20.67 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5x4r | S PROTEIN (MERS-CoV) | 5 / 11 | VAL A 315TYR A 85GLY A 115GLY A 255ASP A 83 | 1.65A | 20.84 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5x4s | SPIKE GLYCOPROTEIN (SARSr-CoV) | 6 / 12 | PHE A 185ALA A 250ALA A 233TRP A 101GLY A 100ALA A 90 | 1.69A | 19.08 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 5x58 | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 9 | ASP B 518PHE B 529SER B 310GLY B 311THR B 539 | 1.71A | 18.89 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 5x59 | S PROTEIN (MERS-CoV) | 5 / 12 | ILE A 143ILE A 300ALA A 89ALA A 138GLY A 128 | 1.29A | 16.25 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5x5b | SPIKE GLYCOPROTEIN (SARS-COVBJ01) | 5 / 11 | VAL A 562GLY A 534PHE A 527GLY A 531ASP A 560 | 1.62A | 18.43 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5x5c | S PROTEIN (MERS-CoV) | 5 / 11 | VAL B 374ALA B 597GLY B 615PHE B 617GLY B 372 | 1.47A | 17.77 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 5y3q | REPLICASEPOLYPROTEIN 1A (SARSr-CoV) | 5 / 11 | ALA A 140TYR A 137GLY A 101SER A 104GLY A 143 | 1.50A | 22.41 | NoneNoneNone NA A 405 ( 3.9A)None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 5zvm | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | ILE B 955SER C 950PHE B 952SER B 957GLY B 953 | 1.50A | 9.98 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | PHE B 231LEU B 235ALA B 251THR B 92ALA B 90 | 1.23A | 16.36 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 11 | TYR B 660VAL B 642TYR B 677SER B 659ASP B 643 | 1.29A | 18.37 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6ack | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | ASN A 155ILE A 226SER A 111SER A 105GLY A 104 | 1.44A | 19.01 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 11 | VAL C 642ALA C 676TYR C 677SER C 659ASP C 643 | 1.62A | 16.94 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | ILE C 226PHE C 130SER C 105GLY C 104THR C 160 | 1.76A | 18.72 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6crv | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | ALA B 695ALA C 866GLY C 862ALA C 874THR C 869 | 1.20A | 17.05 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 9 | ASN C 692SER C 690PHE A 779GLY A 781THR A 775 | 1.40A | 18.72 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6crw | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 11 | ASP B 191ALA A 406TYR A 410GLY A 400ASP A 385 | 1.35A | 17.42 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6crz | SPIKEGLYCOPROTEIN,FIBRITIN (SARSr-CoV) | 5 / 12 | LEU B1045ILE B 800ALA B 926GLY B 928THR B 706 | 1.08A | 16.67 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6kl2 | NUCLEOPROTEIN (MERS-CoV) | 5 / 11 | VAL A 116ALA A 115GLY B 76PHE B 113ASP A 118 | 1.38A | 13.79 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 9 | ASN A 54SER A 278PHE A 283SER A 431GLY A 434 | 1.00A | 32.53 | NoneNoneLEU A 707 (-3.8A)LEU A 707 (-4.2A)None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6m17 | SODIUM-DEPENDENTNEUTRAL AMINO ACIDTRANSPORTER B(0)AT1 (Homosapiens) | 5 / 11 | VAL C 125TYR C 128TYR C 129SER C 431ASP C 486 | 0.75A | 27.17 | NoneNoneLEU C 707 ( 3.9A)LEU C 707 (-4.2A)None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6m1d | ACE2 (Homosapiens) | 5 / 9 | ASP B 719ASN B 718ILE B 704SER B 721GLY B 726 | 1.12A | 20.99 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 9 | ASN B 692SER B 690PHE A 779GLY A 781THR A 775 | 1.55A | 18.84 | NAG B1326 (-3.5A)NoneNoneNoneNone | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6nb6 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 11 | VAL B 642ALA B 676TYR B 677SER B 659ASP B 643 | 1.61A | 17.02 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6nb7 | SPIKE GLYCOPROTEIN (SARSr-CoV) | 5 / 12 | LEU A1045ILE A 800ALA A 926GLY A 928THR A 706 | 1.09A | 16.18 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6nb8 | S230 ANTIGEN-BINDING(FAB) FRAGMENT,LIGHT CHAIN (Homosapiens) | 5 / 9 | ILE L 21SER L 25SER L 70GLY L 69THR L 107 | 1.65A | 15.36 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6nur | NSP12NSP7 (SARSr-CoV) | 5 / 11 | VAL A 424ALA A 423TYR A 420GLY A 432ASP C 5 | 1.65A | 18.93 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6nur | NSP12NSP8 (SARSr-CoV) | 5 / 9 | ASP A 269ILE B 106SER A 325GLY B 113THR B 124 | 1.75A | 20.42 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6vw1 | SARS-COV-2 CHIMERICRBD (SARSr) | 5 / 11 | ALA F 419TYR F 423PHE F 429GLY F 413ASP F 398 | 1.22A | 15.89 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6vw1 | SARS-COV-2 CHIMERICRBD (SARSr) | 5 / 11 | ALA E 419TYR E 423PHE E 429GLY E 413ASP E 398 | 1.27A | 15.89 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 12 | PHE L 62ILE L 75ALA L 19GLY L 101ALA L 84 | 1.78A | 18.50 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 11 | TYR H 90GLY H 65SER H 60GLY H 49ASP H 86 | 1.57A | 15.78 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 9 | ASP H 54ILE H 98SER H 55GLY H 97THR L 94 | 1.65A | 15.09 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6w41 | CR3022 FAB HEAVYCHAINCR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 9 | ILE H 98SER H 55SER H 96GLY H 95THR L 94 | 1.71A | 15.09 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6w41 | CR3022 FAB HEAVYCHAIN (Homosapiens) | 5 / 12 | PHE H 29ILE H 20ALA H 93GLY H 94ALA H 78 | 1.71A | 16.19 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6w41 | CR3022 FAB LIGHTCHAIN (Homosapiens) | 5 / 9 | ASP L 70SER L 25SER L 65GLY L 64THR L 102 | 1.72A | 14.29 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ILE B 102SER B 56SER B 100GLY B 99THR C 100 | 1.57A | 15.81 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ILE H 102SER H 56SER H 100GLY H 99THR L 100 | 1.53A | 15.81 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 9 | ILE C 21SER C 25SER C 71GLY C 70THR C 108 | 1.72A | 16.54 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | LEU C 52THR C 59ALA C 57GLY C 72ALA C 40 | 1.54A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6yla | LIGHT CHAIN (Homosapiens) | 5 / 12 | LEU L 52THR L 59ALA L 57GLY L 72ALA L 40 | 1.63A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ASP B 55ILE B 102SER B 56GLY B 101THR C 100 | 1.52A | 15.81 | MLI B 302 ( 4.1A)NoneNoneNoneNone | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 11 | TYR H 94GLY H 66SER H 61GLY H 49ASP H 90 | 1.53A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ASP H 55ILE H 102SER H 56GLY H 101THR L 100 | 1.52A | 15.81 | MLI E 908 (-3.9A)NoneNoneNoneNone | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yla | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ILE H 102SER H 56SER H 100GLY H 98THR L 100 | 1.78A | 15.81 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yla | HEAVY CHAIN (Homosapiens) | 5 / 11 | TYR B 94GLY B 66SER B 61GLY B 49ASP B 90 | 1.54A | None | |||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 11 | TYR H 94GLY H 66SER H 61GLY H 49ASP H 90 | 1.55A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6ym0 | LIGHT CHAIN (Homosapiens) | 5 / 12 | LEU L 52THR L 59ALA L 57GLY L 72ALA L 40 | 1.55A | None | |||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6ym0 | HEAVY CHAIN (Homosapiens) | 5 / 12 | PHE H 29ILE H 20ALA H 97GLY H 98ALA H 79 | 1.66A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ILE H 102SER H 56SER H 100GLY H 99THR L 100 | 1.60A | 15.94 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6ym0 | HEAVY CHAINLIGHT CHAIN (Homosapiens) | 5 / 9 | ASP H 55ILE H 102SER H 56GLY H 101THR L 100 | 1.56A | 15.94 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | LEU L 52THR L 59ALA L 57GLY L 72ALA L 40 | 1.62A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ILE B 102SER B 56SER B 100GLY B 98THR C 100 | 1.77A | 15.81 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ILE H 102SER H 56SER H 100GLY H 99THR L 100 | 1.54A | 15.81 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 11 | TYR B 94GLY B 66SER B 61GLY B 49ASP B 90 | 1.53A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ASP H 55ILE H 102SER H 56GLY H 101THR L 100 | 1.52A | 15.81 | None | ||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ILE H 102SER H 56SER H 100GLY H 98THR L 100 | 1.78A | 15.81 | None | ||
![]() | 4MM9_A_FVXA603_1 (TRANSPORTER) | 6yor | IGG H CHAIN (Homosapiens) | 5 / 11 | TYR H 94GLY H 66SER H 61GLY H 49ASP H 90 | 1.52A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ASP B 55ILE B 102SER B 56GLY B 101THR C 100 | 1.52A | 15.81 | None | ||
![]() | 4ENH_A_FVXA602_1 (CHOLESTEROL24-HYDROXYLASE) | 6yor | IGG L CHAIN (Homosapiens) | 5 / 12 | LEU C 52THR C 59ALA C 57GLY C 72ALA C 40 | 1.62A | None | |||
![]() | 6AWP_A_FVXA701_1 (SODIUM-DEPENDENTSEROTONINTRANSPORTER) | 6yor | IGG H CHAINIGG L CHAIN (Homosapiens) | 5 / 9 | ILE B 102SER B 56SER B 100GLY B 99THR C 100 | 1.53A | 15.81 | None |